| |
| |
|
| Insider
Information: |
Graf Finckenstein Friedrich |
| Relationship: |
Chief Medical Officer |
| City: |
San Carlos |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
42,562 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$580,120 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
42,562 |
|
|
| Total
Value |
$580,120 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Iovance Biotherapeutics Inc |
IOVA |
Chief Medical Officer |
2024-04-15 |
42,562 |
2022-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2024-04-15 |
4 |
D |
$11.89 |
$16,967 |
D/D |
(1,427) |
42,562 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
43,989 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2024-03-04 |
4 |
D |
$16.96 |
$136,579 |
D/D |
(8,053) |
41,177 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,623 |
49,230 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2024-01-16 |
4 |
D |
$8.37 |
$13,199 |
D/D |
(1,577) |
33,607 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
35,184 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2023-10-16 |
4 |
D |
$3.57 |
$4,980 |
D/D |
(1,395) |
32,371 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2023-10-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
33,766 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2023-07-14 |
4 |
D |
$7.76 |
$10,825 |
D/D |
(1,395) |
30,953 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2023-07-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
32,348 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2023-04-14 |
4 |
D |
$5.64 |
$7,868 |
D/D |
(1,395) |
29,535 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2023-04-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
30,930 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2023-01-17 |
4 |
D |
$6.43 |
$30,080 |
D/D |
(4,678) |
28,118 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,248 |
32,796 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2023-01-03 |
4 |
D |
$6.11 |
$67,351 |
D/D |
(11,023) |
21,548 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,690 |
32,571 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2022-06-14 |
4 |
D |
$7.73 |
$52,634 |
D/D |
(6,809) |
12,881 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Chief Medical Officer |
• – – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,690 |
19,690 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
